A shift in voter support is reshaping political landscapes in key regions, as some traditionally strongholds for a major candidate show signs of waning allegiance amid evolving priorities and demographic changes. Meanwhile, the development of groundbreaking cancer treatments faces significant hurdles, with high costs and regulatory challenges slowing progress in bringing life-saving innovations to patients in need. Experts warn that these barriers could delay access to therapies that have shown promise in early trials. The article examines both the political realignment and the scientific obstacles standing between research and real-world impact.
Where Voters Are Abandoning Trump, and Barriers to New Cancer Treatments The New York Times
